Send SMS
+918068092906
Home » Products » Cardiovascular Devices » Quo-Test

Quo-Test

Quo-Test
Quo-Test
Send Inquiry
Product Code : 05
Brand Name : MATRIX MEDI SERVICES
Price And Quantity
  • Minimum Order Quantity
  • 1
  • Unit of Measure
  • Piece/Pieces
Product Description

Quo-Test is a medical machine which consists of an analyzer, test cartridges, and a quality control kit for calibration purpose. It is a type of automatic device which is mainly utilized for HbA1C testing by adding blood sample into the cartridge and placing it inside analyzer. This test is used for monitoring and treatment of diabetic patients by quantitative examination of glycosylated hemoglobin.  Offered Quo-Test is highly appreciated for its fast & simple operation, compact structure, and reliable results.

Features:

  • Requires only 4 microlitre blood sample

  • Easy to calibrate

  • Work on the principle of affinity quenching fluorescence technology


Easy and reliable HbA1c measurement :

  • Fully automated analyzer
  • Fast and accurate
  • Easy to use
  • Results in just 4 minutes

Simple, accurate and reliable HbA1c measurement  :

Easy to use

Intuitive, step by step on screen instructions minimise training time
Step by step instructions on display
Multi-lingual menu
Just 4µl blood required from finger prick or venous sample

Efficient data handling

Barcode reader included. Only one scan per lot of cartridges required
Stores up to 7000 results for efficient patient data management
User selectable dual reporting. User can select % DCCT, IFCC mmol/mol, eAG mg/dl or eAG mmol/l.
USB Port
Optional label printer available

Fast and accurate

Results within 4 minutes
Boronate affinity method which is recognized as interference free
Measuring range: 4-15% A1c DCCT
Imprecision: CV <3% at 7% A1c DCCT
Unaffected by Hb variants, which do not result in reduced erythrocyte life span
Traceable to the IFCC reference method

Ergonomic design

Compact: 205 mm(h) x 205 mm(w) x 135 mm(d)
Lightweight: 1.3kg

Q: How long does it take to perform a glycated hemoglobin (HbA1c) test?

A: Once a blood sample has been introduced into the Quo-Test results are reported within 4 minutes.

Q: How much blood is required?

A: Just 4 µL is required from a finger prick, capillary or venous sample.

Q: What technology is being used?

A: Quo-Test uses a patented Boronate Fluorescence Quenching Technology (BFQT) associated with simple yet powerful multiple optical measurements.

Q: What is the benefit of BFQT?

A: Based on well documented boronate affinity for glycated hemoglobin, the BFQT has similar performances as the boronate affinity chromatography systems used in reference laboratories. However, as it does not require physical separation it assures a simple, fast and accurate measurement.
The Quo-Test system using the BFQT has the advantage of not being affected by hemoglobin variants (which do not result in reduced erythrocyte life span), labile glycated hemoglobin or hematocrit levels.

Q: How are results reported?

A: Results are displayed on the digital display and reported in mmol/mol IFCC, % DCCT, % JDS, eAG mg/dl and eAG mmol/l values.

Q: Does it store patient results?

A: Yes, the Quo-Test can store up to 7,000 results which can be downloaded to a PC via a USB cable.

Q: Does the instrument have a NGSP and IFCC certification?

A: Yes, the Quo-Test analyser has been certified to the NGSP and IFCC standard.

Q: What is NGSP and IFCC certification?

A: In an effort to standardize glycated haemoglobin results the AACC has set up the "National Glycohemoglobin Standardization Program" (NGSP) in 1996. In parallel the International Federation of Clinical Chemistry (IFCC) developed reference methods for glycated haemoglobin. In 2006 and 2007, an international consensus between IFCC and AACC was agreed upon.
The calibration and certification of laboratories and manufacturers to the same standards have improved the conformity of the results.
However, in practice differences can still be observed among technologies as well as between individual systems either because of the heterogeneity of haemoglobines, underlying different technologies (e.g. ion exchange, boronate affinity, Immunoassay) due to calibration drifts, or lot to lot variability. This ,may result in differences in reported values. EKF
Diagnostics follows the recommendations of the IFCC eand NGSP to ensure that our instruments and reagents are accurately aligned and traceable to the reference method. See www.ngsp.org for more information.

Q: Can the Quo-Test be used in laboratories?

A: Yes, although the Quo-Test has been developed to be used in a point of care setting, it is a professional product providing laboratory level accuracy.

Q: Is there a warranty period?

A: Yes, all Quo-Test analysers carry a 12 month worldwide warranty.

Q: What languages are featured on the device?

A: Quo-Test can be set up in English, Czech, Danish, Dutch, Finnish, French, German, Italian, Spanish, Russian, Polish, Romanian, Portuguese, Bosnian, Bulgarian, Croatian, Estonian, Greek, Kazakh, Latvian, Lithuanian, Serbian, Slovakian, Swedish, Turkish, and Chinese. Ask your EKF representative for details.

Q: Where is the EKF Quo-Test HbA1c analyser produced?

A: It is assembled at EKF Diagnostics ISO 13485:2012/2003 accredited manufacturing facility in Germany.

AACC

American Association for Clinical Chemistry

BFQT

Boronate Fluorescence Quenching Technology

DCCT

Diabetes Complications and Control Trial

IFCC

International Federation of Clinical Chemistry

NGSP

National Glycohemoglobin Standardization Program

Trade Information
  • Payment Terms
  • Cheque, Telegraphic Transfer (T/T), Others
  • Supply Ability
  • as per order Per Month
  • Delivery Time
  • as per order Week
  • Packaging Details
  • as per requirements
  • Main Domestic Market
  • All India

MATRIX MEDI SERVICES
X


Back to top